American Action Forum Issues Commentary: Onshoring Pharmaceutical Manufacturing - Ambiguity Complicates Potential Success
April 29, 2026
April 29, 2026
WASHINGTON, April 29 -- The American Action Forum issued the following commentary on April 28, 2026, by health care policy analyst Jack Leimann:
* * *
Onshoring Pharmaceutical Manufacturing: Ambiguity Complicates Potential Success
Executive Summary
* A prominent objective of the Trump Administration is onshoring pharmaceutical manufacturing to the United States to secure supply lines and enable American pharmaceutical self-reliance; its most re . . .
* * *
Onshoring Pharmaceutical Manufacturing: Ambiguity Complicates Potential Success
Executive Summary
* A prominent objective of the Trump Administration is onshoring pharmaceutical manufacturing to the United States to secure supply lines and enable American pharmaceutical self-reliance; its most re . . .